-
Most Popular
Earnings Reports
INTS Stock Earnings: Intensity Therapeutics Misses EPS for Q2 2024
INTS stock results show that Intensity Therapeutics missed analyst estimates for earnings per share the second quarter of 2024.
IOR Stock Earnings: Income Opportunity Realty Reported Results for Q2 2024
Income Opportunity Realty just reported results for the second quarter of 2024.
NUTX Stock Earnings: Nutex Health Misses EPS, Beats Revenue for Q2 2024
NUTX stock results show that Nutex Health missed analyst estimates for earnings per share but beat on revenue for the second quarter of 2024.
CYBN Stock Earnings: Cybin Beats EPS for Q1 2024
CYBN stock results show that Cybin beat analyst estimates for earnings per share the first quarter of 2024.
CTRM Stock Earnings: Castor Maritime Reported Results for Q2 2024
Castor Maritime just reported results for the second quarter of 2024.
NEON Stock Earnings: Neonode Reported Results for Q2 2024
Neonode just reported results for the second quarter of 2024.
ARL Stock Earnings: American Realty Investors Reported Results for Q2 2024
American Realty Investors just reported results for the second quarter of 2024.
INAB Stock Earnings: IN8bio Misses EPS for Q2 2024
INAB stock results show that IN8bio missed analyst estimates for earnings per share the second quarter of 2024.
CPHC Stock Earnings: Canterbury Park Holding Reported Results for Q2 2024
Canterbury Park Holding just reported results for the second quarter of 2024.
APDN Stock Earnings: Applied DNA Sciences Reported Results for Q3 2024
Applied DNA Sciences just reported results for the third quarter of 2024.
EQ Stock Earnings: Equillium Beats EPS, Beats Revenue for Q2 2024
EQ stock results show that Equillium beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
AXDX Stock Earnings: Accelerate Diagnostics Beats EPS, Misses Revenue for Q2 2024
AXDX stock results show that Accelerate Diagnostics beat analyst estimates for earnings per share but missed on revenue for the second quarter of 2024.
FDMT Stock Earnings: 4D Molecular Therapeutics Beats EPS for Q2 2024
FDMT stock results show that 4D Molecular Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
APTO Stock Earnings: Aptose Biosciences Beats EPS for Q2 2024
APTO stock results show that Aptose Biosciences beat analyst estimates for earnings per share the second quarter of 2024.
CLDX Stock Earnings: Celldex Therapeutics Beats EPS, Beats Revenue for Q2 2024
CLDX stock results show that Celldex Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
DNTH Stock Earnings: Dianthus Therapeutics Beats EPS, Beats Revenue for Q2 2024
DNTH stock results show that Dianthus Therapeutics beat analyst estimates for earnings per share and beat on revenue for the second quarter of 2024.
GPCR Stock Earnings: Structure Therapeutics Beats EPS for Q2 2024
GPCR stock results show that Structure Therapeutics beat analyst estimates for earnings per share the second quarter of 2024.
FRD Stock Earnings: Friedman Industries Reported Results for Q1 2025
Friedman Industries just reported results for the first quarter of 2025.
BHVN Stock Earnings: Biohaven Misses EPS for Q2 2024
BHVN stock results show that Biohaven missed analyst estimates for earnings per share the second quarter of 2024.
